PRESCRIBING SGLT2 INHIBITORS IN ACUTE HEART FAILURE: CONSIDERATIONS FOR DYSGLYCEMIA STATUS, HEART FAILURE PHENOTYPE, AND KIDNEY FUNCTION СтатьяMedovchshikov V.V., Yeshniyazov N., Khasanova E., Zholdin B., Kurmanalina G., Kushimova D., Tleumagambetova B., Amanova A., Kobalava Z.Европейский журнал сердечной недостаточности. Том 26. 2024. С. 591-592
CARDIOVASCULAR DISEASES AND TYPE 2 DIABETES MELLITUS: HIGH HEART FAILURE RISK AND LOW RATE CONTRAINDICATIONS TO SGLT2I СтатьяMedovchshikov V.V., Yeshniyazov N., Khasanova E., Zholdin B., Kurmanalina G., Amanova A., Kobalava Z.Европейский журнал сердечной недостаточности. Том 26. 2024. С. 563-563
THE LOW FREQUENCY OF CONFORMITY BASELINE LDL-C AND TAKING STATINS IN HOSPITALIZED PATIENTS WITH CVD REGARDLESS OF THE STATUS OF CARBOHYDRATE METABOLISM DISORDERS СтатьяMedovchshikov V., Yeshniyazov N., Khasanova E., Bayarsaikhan M., Kobalava Z.Atherosclerosis. Том 331. 2021.
